A September 2026 Whelth Research analysis of 14,748 U.S. Med Spa websites examines how medical weight loss, IV therapy, peptides, and other medical services appear alongside traditional aesthetic treatments.
Whelth Research Examines Medical and Aesthetic Services Listed by U.S. Med Spas
On September 11, 2026, Whelth Research computed an analysis of service information listed on the websites of 14,748 U.S. Med Spas, examining how medical services appear alongside traditional aesthetic treatments. The findings provide industry data on the types of services represented across published Med Spa menus, including prescription weight management, IV therapy, hormone therapy, peptides, and other medical services within practices also associated with aesthetic care.
Report Cites Medical Services Alongside Traditional Med Spa Treatments in Reviewed U.S. Med Spa Menus
Whelth Research reviewed 14,748 Med Spas in its directory with at least one service evidenced on the practice’s own website between July 18 and September 7, 2026, with the final analysis computed September 11. Among those reviewed, 57.3%, or 8,444 Med Spas, listed at least one service included in the report’s definition of a medical intervention.
Whelth Research (2026) reported the following medical services among reviewed Med Spas:
- Medical weight loss: 40.1%
- IV therapy: 35.5%
- Hormone replacement therapy: 18.9%
- NAD+ therapy: 13%
- Peptide therapy: 11.4%
Medical weight loss ranked as the sixth most frequently listed service overall, behind neuromodulators, microneedling, chemical peels, dermal fillers, and laser hair removal. Among Med Spas listing at least one defined medical intervention, 84.6% also listed Botox or another neuromodulator.
Geographic differences also appeared in the findings. Among states with at least 100 reviewed Med Spas, Utah had the highest share of reviewed Med Spas listing medical weight loss at 48.6%, followed by Florida at 48.5%, Arkansas at 48.4%, and Arizona at 48.1%. Mississippi had the lowest reported share at 25%.
Other findings reported by Whelth Research (2026) included:
- Medical interventions: 57.3% of reviewed Med Spas listed at least one defined medical intervention, compared with 29.7% of 4,699 reviewed plastic surgery and dermatology practices.
- Medical weight loss: 40.1% of reviewed Med Spas listed medical weight loss, compared with 20.6% of the reviewed plastic surgery and dermatology practices.
- IV or NAD+ therapy: 38.3% of reviewed Med Spas listed IV or NAD+ therapy, compared with 9.9% of the reviewed plastic surgery and dermatology practices.
The report also examines medical-service listings by metro area and provides additional findings involving hormone therapy, diagnostic services, individual aesthetic treatments, and geographic differences. Whelth Research noted that the findings describe services identified on published websites rather than clinical conduct and do not estimate the total number of Med Spas operating in the United States.
Source Publication
According to Whelth Research, The State of America’s Med Spas — 2026 was published in September 2026 using service information identified across reviewed U.S. Med Spa websites. Data were collected from July 18 through September 7, 2026, with the analysis computed on September 11.
Detailed Findings and Industry Context for Med Spa Operators
Beyond the national service percentages, the Whelth Research report provides state- and metro-level comparisons of medical weight loss and other services identified across reviewed Med Spa websites. These findings show how frequently specific services appeared across different markets.
Medical weight loss and IV therapy ranked among the most frequently listed medical services across the 14,748 Med Spas Whelth Research reviewed. GLP-1 medications also remain an active area of pharmaceutical development, with the FDA issuing draft guidance in 2026 for generic GLP-1 drug development. Peptide therapy, listed by 11.4% of reviewed Med Spas, represents another medical service category identified in the report.
Other research provides additional context for the service mix. A 2026 JMIR Dermatology study comparing U.S. search interest in Med Spas and dermatologists found higher relative search volumes for Med Spa queries involving lip fillers, Botox, laser hair removal, and microneedling. Separately, data published in April 2026 estimated the global longevity market could reach $67.03 billion by 2035, with preventive care, personalized medicine, and wellness services among the factors associated with projected market growth.
For Med Spa and aesthetic operators, the findings provide industry insight into the aesthetic, medical, and wellness services represented across the field. As practice models encompass services ranging from traditional aesthetics to prescription weight management, IV therapy, hormone therapy, and peptides, applicable state and federal requirements provide additional context for evaluating individual treatments within a practice model.
Medical weight loss and IV therapy ranked among the most frequently listed medical services across the 14,748 Med Spas.
— Whelth Research (2026)
Educational and Operational Implications for Med Spa and Aesthetic Operators
- Evaluate how evolving Med Spa practice models incorporate aesthetic, medical, and wellness services when assessing service offerings and industry trends.
- Review state-specific and federal requirements for prescription weight-management, IV, hormone, or peptide services added to service menus.
- Compare national, state, and metro-level service data to understand how medical and wellness service listings differ across Med Spa markets.
- Align website service descriptions with available treatments and the qualifications of the practitioners providing them.
- Maintain service-specific protocols addressing patient evaluation, documentation, treatment delivery, and adverse-event response.
What to Watch Next
Future updates to Whelth Research’s Med Spa data may provide additional insight into how medical, wellness, and aesthetic service offerings develop across U.S. markets. Changes in medical weight loss, IV therapy, hormone therapy, peptides, and other service categories may be relevant as operators evaluate industry trends and evolving practice models.
About Spakinect
Spakinect provides compliance infrastructure and telehealth-supported supervision solutions for medical aesthetic practices. For additional information, see our website.
Image Attribution: “Medical IV Drip Bag” by Vladislav Stepanov, via Vecteezy, available under the Vecteezy Free License.
